PQR-514

N/A

Report date: 2023/05/22 10:20:16
NME

Base Information

Drug NamePQR-514
Drug Alias NamePQR-514
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPiqur Therapeutics Ag
China Registration ClassN/A

Develop Information

Active CompaniesPiqur Therapeutics Ag
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A